|
MedChemExpress
intratracheal instillation Intratracheal Instillation, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/Bleomycin+hydrochloride/pmc13279423-114-6-10 Average 96 stars, based on 1 article reviews
intratracheal instillation - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Bleomycin A5 hydrochloride is a compound part of the glycopeptide antibiotic family. It is currently used in oncology research for its strong stimulatory and inhibitory effects. Bleomycin A5 greatly reduces telomerase activity, hindering the proliferation
|
Buy from Supplier |
|
LKT Laboratories
bleomycin a5 hydrochloride ![]() Bleomycin A5 Hydrochloride, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/Bleomycin+A5+Hydrochloride/pm25958390-109-23-26 Average 93 stars, based on 1 article reviews
bleomycin a5 hydrochloride - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Biosynth Carbosynth
bleomycin a5 hydrochloride ![]() Bleomycin A5 Hydrochloride, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/Bleomycin+A5+hydrochloride/pm33819606-50-12-15 Average 91 stars, based on 1 article reviews
bleomycin a5 hydrochloride - by Bioz Stars,
2026-10
91/100 stars
|
Buy from Supplier |
|
Merck KGaA
bleomycin a5 hydrochloride bleocin ![]() Bleomycin A5 Hydrochloride Bleocin, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/bleomycin+a5+hydrochloride+bleocin/pmc12181080-212-20-31 Average 90 stars, based on 1 article reviews
bleomycin a5 hydrochloride bleocin - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Nippon Kayaku
bleomycin hydrochloride ![]() Bleomycin Hydrochloride, supplied by Nippon Kayaku, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/bleomycin+blm+hydrochloride+injection/pmc12657345-87-1-5 Average 86 stars, based on 1 article reviews
bleomycin hydrochloride - by Bioz Stars,
2026-10
86/100 stars
|
Buy from Supplier |
|
GlpBio Technology Inc
bleomycin hydrochloride #gc60089 ![]() Bleomycin Hydrochloride #Gc60089, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bleomycin+hydrochloride/bleomycin+hydrochloride++gc60089/pm37120058-78-0-10 Average 90 stars, based on 1 article reviews
bleomycin hydrochloride #gc60089 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Bleomycin A5 Hydrochloride Salt
|
Buy from Supplier |
|
Bleomycin hydrochloride is a DNA synthesis inhibitor. Bleomycin hydrochloride is a DNA damaging agent. Bleomycin hydrochloride is an antitumor antibiotic.In VitroBleomycin hydrochloride is chosen as the best-studied micronucleus inducers in human lymphocytes with different mechanisms
|
Buy from Supplier |
|
Bleomycin A5 inhibits DNA replication and repair. It also cleaves RNA in vitro and in vivo, and exhibits anticancer activity. It is used for various types of cancer such as squamous cell cancers, melanoma, sarcoma,
|
Buy from Supplier |
Image Search Results
Journal: Mutagenesis
Article Title: Functional analysis of the new barley gene HvKu80 indicates that it plays a key role in double-strand DNA break repair and telomere length regulation.
doi: 10.1093/mutage/gev033
Figure Lengend Snippet: Figure 4. Relative HvKu80 gene expression levels in the parent cultivar ‘Sebastian’ (A), mutant ku80.c (B) and mutant ku80.j (C) after the treatment with bleomycin (100 µg/ml) and in the untreated material were analysed at various time points. ‘C’: seedlings after 36 h of growth at 24°C, ‘0’ in the untreated material denotes 36-h-old seedlings of barley that were treated with sterile water for 2 h at 37°C, ‘0’ in the treated material denotes 36-hold seedlings of barley that were treated with bleomycin for 2 h at 37°C. The value of the relative expression level was normalised to the standard control (HvARF1 gene, accession no. AJ508228.2). The expression level (2−ΔΔCt) in the untreated material was calculated relative to the control roots (C). The expression level (2−ΔΔCt) in the treated material was calculated relative to the untreated material at a particular time point. #Statistically significant difference vs. the control (C) (P < 0.05); *Statistically significant difference compared to the untreated material at the corresponding time point (P < 0.05).
Article Snippet: After this time, the seeds were incubated at 24°C for 36 h. Thirty-six-hour-old barley seedlings were transferred to 100 μg/ ml solution of
Techniques: Gene Expression, Mutagenesis, Sterility, Expressing, Control
Journal: Mutagenesis
Article Title: Functional analysis of the new barley gene HvKu80 indicates that it plays a key role in double-strand DNA break repair and telomere length regulation.
doi: 10.1093/mutage/gev033
Figure Lengend Snippet: Figure 5. The number of DSBs that were induced by bleomycin. Ethidium bromide-stained agarose gel visualising the induction of DSBs by bleomycin treatment in barley genomic DNA (A), concentration-dependent increase in DSB number in roots of the cultivar ‘Sebastian’ (B), the number of DSBs that were induced by 100 µg/ml bleomycin in the roots of the parent cultivar ‘Sebastian’ and the mutants ku80 after the bleomycin treatment (C). The DSB frequency was calculated for whole roots of the analysed genotypes. ‘M’: marker size 1 kb, ‘C’: measurement of DSB number was done on DNA isolated from whole roots after 36 h of growth at 24°C, ‘0’-treated material: measurement of DSB number was done on DNA isolated from whole 36-h-old roots of barley that were treated with bleomycin for 2 h at 37°C, *Statistically significant difference in relation to the parent cultivar ‘Sebastian’ (P < 0.05) at corresponding time points, #Statistically significant difference in relation to 0 µg/ml concentration of bleomycin (P < 0.05).
Article Snippet: After this time, the seeds were incubated at 24°C for 36 h. Thirty-six-hour-old barley seedlings were transferred to 100 μg/ ml solution of
Techniques: Staining, Agarose Gel Electrophoresis, Concentration Assay, Marker, Isolation
Journal: Mutagenesis
Article Title: Functional analysis of the new barley gene HvKu80 indicates that it plays a key role in double-strand DNA break repair and telomere length regulation.
doi: 10.1093/mutage/gev033
Figure Lengend Snippet: Figure 6. Number of MCD nuclei after the treatment of the roots of the cultivar ‘Sebastian’ and the mutants ku80.c and ku80.j with bleomycin. ‘C’: seedlings after 36 h of growth at 24°C, ‘0’-treated material: 36-h-old barley seedlings that were treated with bleomycin for 2 h at 37°C; *Statistically significant difference in relation to the parent cultivar ‘Sebastian’ (P < 0.05) at corresponding time points.
Article Snippet: After this time, the seeds were incubated at 24°C for 36 h. Thirty-six-hour-old barley seedlings were transferred to 100 μg/ ml solution of
Techniques:
Journal: Mutagenesis
Article Title: Functional analysis of the new barley gene HvKu80 indicates that it plays a key role in double-strand DNA break repair and telomere length regulation.
doi: 10.1093/mutage/gev033
Figure Lengend Snippet: Figure 7. Reduced growth of seedlings from the cultivar ‘Sebastian’ and the mutants ku80.c and ku80.j after treatment with bleomycin (100 µg/ml). Representative image of seedlings from the cultivar ‘Sebastian’ and the mutants ku80.c and ku80.j after treatment with bleomycin (A). Reduction of roots and shoots length of cultivar ‘Sebastian’ and the mutants ku80.c and ku80.j after bleomycin treatment (B). Control; ‘C’: seedlings after 60 h of growth at 24°C; scale = 3 cm, *Statistically significant difference in relation to root or shoot in control conditions (P < 0.05).
Article Snippet: After this time, the seeds were incubated at 24°C for 36 h. Thirty-six-hour-old barley seedlings were transferred to 100 μg/ ml solution of
Techniques: Control
Journal: Journal of pharmacological and toxicological methods
Article Title: A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin.
doi: 10.1016/j.vascn.2021.107057
Figure Lengend Snippet: Fig. 1. Representative images of Ashcroft scoring. Images captured using a x20 objective lens. The images show a healthy lung section with an Ashcroft score of 0 (A) and sections with Ashcroft scores of 2 (B), 3 (C) and 4 (D). Average scores of 2–4 are what are most commonly observed in bleomycin treated animals.
Article Snippet: Mice were administered 6 intranasal doses of either saline or 0.25 mg/kg
Techniques:
Journal: Journal of pharmacological and toxicological methods
Article Title: A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin.
doi: 10.1016/j.vascn.2021.107057
Figure Lengend Snippet: Fig. 3. Lung function and histological changes confirm successful induction of IPF. A decline in lung function is seen in the bleomycin-dosed animals that is consistent with what would be expected in IPF. The decline in FVC (A) shows a decrease in the ability of the lung to draw in and expel air. This is likely due to the increase stiffness of the scarred lung tissue as demonstrated by the increase in elastance (B). The induction of IPF in the animals was confirmed histo pathologically by observing a significant increase in Ashcroft score (C). An increase in the number of platelets recovered in the BAL was observed (D), this was correlated by an increase in the number of platelets observed in the lung tissue of bleomycin treated animals (E). n = 7–11 per group. Data is means± SEM. ** p < 0.01, *** p < 0.001 compared to saline treated group.
Article Snippet: Mice were administered 6 intranasal doses of either saline or 0.25 mg/kg
Techniques: Saline
Journal: Journal of pharmacological and toxicological methods
Article Title: A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin.
doi: 10.1016/j.vascn.2021.107057
Figure Lengend Snippet: Fig. 2. Determination of standardized threshold for quantitative anal ysis of lung tissue sections in ImageJ. Threshold is chosen based on the criteria of minimal noise signal being presented as well as least platelets being lost in the resulting grey and grayscale image when comparing to the RGB images and DAB component images. (A) and (D) Representa tive CD41 immunostaining of lung tissue sections (x40 magnification) of sham and bleomycin-induced IPF mice respectively, taken under light microscopy. Platelets are immuno-stained in brown while lung tissues are counterstained in blue. (B) and (E) Representative DAB component images obtained from (A) and (D) respectively after processing with a colour deconvolution plugin. (C) and (F) Resulting representative grey and grayscale images produced after (B) and (E) underwent thresh olding of 130. Black dots represents platelets that will be counted in the subsequent quantitative analysis of number and size of platelets after a suitable size filter is chosen.
Article Snippet: Mice were administered 6 intranasal doses of either saline or 0.25 mg/kg
Techniques: Immunostaining, Light Microscopy, Staining, Produced
Journal: Journal of pharmacological and toxicological methods
Article Title: A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin.
doi: 10.1016/j.vascn.2021.107057
Figure Lengend Snippet: Fig. 5. Effect of platelet depletion on development of fibrotic endpoints. The success of the platelet depletion was confirmed by measuring circulating platelet levels in n = 3 animals from the saline treated platelet normal and platelet depleted animals (A). An improved survival rate was observed in platelet depleted animals compared to platelet normal animals treated with bleomycin (B). There was also an improved recovery in initial weight loss observed in platelet depleted animals compared to platelet normal animals treated with bleomycin (C). An increase in platelet numbers recovered in the BAL was observed in both the platelet normal and platelet depleted bleomycin treated animals compared to the saline treated controls. There was no difference in the number of platelets in the BAL of the platelet- normal and platelet-depleted bleomycin treated animals (D). An improvement in lung function was observed in platelet-depleted bleomycin treated animals as seen by an increase in FVC (E) and a decrease in elastance (F) compared to the platelet normal bleomycin treated animals. A significant improvement in Ashcroft score was also recorded in platelet-depleted bleomycin treated animals compared to platelet-normal bleomycin treated animals (G). A reduction in TGF-β concentration in the BAL of platelet-depleted animals compared to platelet-normal bleomycin treated animals was also observed (H).). n = 7–11 per group. Data are represented as mean ± SEM. * p < 0.05 ** p < 0.01, *** p < 0.001 compared to saline treated group. ## p < 0.01 compared to the platelet normal group. For the TGF-β analysis where 66% or greater of the group had values that were below the level of quantification (BLQ) the whole group is reported as BLQ. Where less than 66% of the group are outside the limits of quantification 0.5× the lowest level of quantification (LLOQ) has been used for the purposes of deriving a group mean. The LLOQ for this assay was 31.3 pg/mL.
Article Snippet: Mice were administered 6 intranasal doses of either saline or 0.25 mg/kg
Techniques: Saline, Concentration Assay
Journal: Nature Plants
Article Title: Suppression of plastid-to-nucleus gene transfer by DNA double-strand break repair
doi: 10.1038/s41477-025-02005-w
Figure Lengend Snippet: a , The main pathways of DSBR in eukaryotes. LIG4 and POLQ are the main factors acting in NHEJ and TMEJ, respectively. b , Physical map of the engineered region in the plastid genome of Nt-RB98 plants containing an EGT reporter between the trnfM and trnG genes. nptII is a kanamycin resistance marker under the control of the strong nuclear CaMV (cauliflower mosaic virus) 35S promoter. Cells can become kanamycin resistant only upon translocation of this cassette to the nucleus. The aadA gene is under the control of the strong plastid promoter P rrn and confers constitutive resistance to spectinomycin. c , Plants after 45 days of growth in sterile culture followed by 24 days of growth in soil. The images are representative of three independent cultivation experiments. Scale bar, 20 cm. d , Seedlings germinated in medium containing bleomycin (a DSB-generating drug) at 17 days after sowing. At 0.5 mg l −1 , bleomycin sensitivity is evidenced by pointed cotyledons and the lack of true leaves in the lig4 mutants, whereas in polq mutants, the emerging true leaves (white arrows) are narrow and stunted compared with the Nt-RB98 control (black arrows). At 2.5 mg l −1 bleomycin, lig4 mutants fail to grow, and polq mutants display pointed cotyledons. The images are representative of two independent experiments. Scale bar, 1 cm.
Article Snippet: Surface-sterilized seeds from mutant lines and control tobacco plants were sown directly on medium containing 0, 0.5 or 2.5 mg
Techniques: Marker, Control, Virus, Translocation Assay, Sterility
Journal: Frontiers in Medicine
Article Title: CT-guided percutaneous aspiration and bleomycin sclerotherapy for symptomatic hepatic cysts: technique and three-year outcomes
doi: 10.3389/fmed.2025.1687375
Figure Lengend Snippet: The single-pass single-needle puncturing technique of CT-guided percutaneous needle aspiration and bleomycin sclerotherapy for a 67-year-old male patient with solitary hepatic cyst. A 10-cm 21-gage Chiba needle was inserted into the cyst in the left liver lobe under CT guidance (A) . After the first 10 mL of aspirated cyst fluid was sent to the laboratory for examination, 10 mL of diluted contrast media was injected into the cyst to confirm that there was no communication between the cyst and the biliary system (B) . The cyst fluid was then evacuated almost completely (C) . The repeat CT scan showed no leakage after injection of the half-dose Bleomycin solution contained diluted contrast media (D) . The postprocedure CT scan showed that bleomycin solution was stayed in the cyst cavity (E) .
Article Snippet: Subsequently,
Techniques: Injection, Computed Tomography
Journal: Frontiers in Medicine
Article Title: CT-guided percutaneous aspiration and bleomycin sclerotherapy for symptomatic hepatic cysts: technique and three-year outcomes
doi: 10.3389/fmed.2025.1687375
Figure Lengend Snippet: The single-point multi-angulated puncturing technique of CT-guided percutaneous needle aspiration and bleomycin sclerotherapy for three cysts in a 70-year-old female patient with polycystic liver disease. A 15-cm 21-gage Chiba needle was inserted toward the ventral orientation from the right midaxillary line, and went through the cyst located in the lateral section of liver segment V and entered into the cyst located in the medial section of liver segment V (A) . The cyst located in the medial section of liver segment V was evacuated completely (B) , and bleomycin solution contained diluted contrast media was injected into the cyst cavity without evidence of leakage (C) . The needle was then withdrawn into the cyst located in the lateral section of liver segment V, the procedure of aspiration and sclerotherapy was repeated (D) . Next, the needle was drawn back to the subcutaneous layer, and than was inserted toward the dorsal orientation from the right midaxillary line and entered into the cyst located in liver segment VI; the procedure of aspiration and sclerotherapy was performed (E) . The postprocedure CT scan revealed that bleomycin solution remained behind in three cysts without evidence of spillage (F) .
Article Snippet: Subsequently,
Techniques: Injection, Computed Tomography
Journal: Frontiers in Medicine
Article Title: CT-guided percutaneous aspiration and bleomycin sclerotherapy for symptomatic hepatic cysts: technique and three-year outcomes
doi: 10.3389/fmed.2025.1687375
Figure Lengend Snippet: The operation procedure of CT-guided percutaneous catheter aspiration and bleomycin sclerotherapy for a 64-year-old female patient with a giant liver cyst in polycystic liver disease. After inserting percutaneously a 8.5-Fr drainage catheter into the acyst cavity using the Seldinger technique, the position of the tip of central venous catheter (arrowhead) was confirmed by the control CT scan (A) . A recheck CT scan on the next day showed complete evacuation of the cyst (B) . After injection of bleomycin solution and removal of pigtail catheter, postprocedure CT scan showed nonoccurrence of sclerosant extravasation (C) .
Article Snippet: Subsequently,
Techniques: Control, Computed Tomography, Injection
Journal: Frontiers in Medicine
Article Title: CT-guided percutaneous aspiration and bleomycin sclerotherapy for symptomatic hepatic cysts: technique and three-year outcomes
doi: 10.3389/fmed.2025.1687375
Figure Lengend Snippet: A typical example of the imaging-based treatment response after CT-guided percutaneous aspiration and bleomycin sclerotherapy in a 69-year-old man with a simple left renal cyst. Preprocedural CT scan shows an initial cyst volume of 554.4 mL (12.6 cm × 8.8 cm × 10.0 cm in size) (A) . At 6-month follow-up, CT shows a cyst volume of 34.3 mL (4.9 cm × 3.5 cm × 4.0 cm in size) and the volume reduction rate (VRR) of 93.8% (B) . At 12-month follow-up, CT shows a cyst volume of 1.7 mL (20.0 mm × 13.3 mm × 13.0 mm in size) and the volume reduction rate (VRR) of 99.7% (C) . At 24-month follow-up, US shows a cyst volume of 1.2 mL (15.6 mm × 12.4 mm × 13.0 mm in size) and the volume reduction rate (VRR) of 99.8% (D) . At 36-month follow-up, US shows a cyst volume of 0.7 mL (12.6 mm × 9.8 mm × 12.0 mm in size) and the volume reduction rate (VRR) of 99.9% (E) .
Article Snippet: Subsequently,
Techniques: Imaging, Computed Tomography